What should you know about MRSA osteomyelitis treatment?

MRSA osteomyelitis is a bone infection caused by a strain of Staphylococcus aureus that resists several antibiotics. The treatment plan depends on where the infection is, how deep it extends, whether an implant or wound is involved, and your general health. Clinicians may use blood tests, imaging and cultures from blood, wound fluid or bone to select an antibiotic that reaches the infection and matches the laboratory result.

Source control means dealing with material that keeps infection active. This may involve draining an abscess, cleaning infected tissue, treating a wound or reviewing implanted hardware. Antibiotics alone may not be enough when infected tissue or a collection remains.

Take each dose exactly as directed and keep every monitoring appointment. Your team may check symptoms, wound appearance, blood results, kidney function or medication levels, depending on the chosen treatment. Report rash, breathing difficulty, severe diarrhoea, unusual weakness or reduced urine quickly. Protect the affected area as advised, keep dressings clean and avoid changing weight-bearing or activity limits without guidance. When infection has left a bone defect, [Bone Grafting](/treatments/trauma-and-fracture-care/bone-grafting/) may be discussed after the infection plan and bone condition have been assessed.

Seek urgent assessment if fever returns, pain or swelling is worsening, redness spreads, drainage increases, or you feel faint or confused. Get immediate help for breathing problems, facial swelling, a cold or numb limb, or inability to move the affected area. Symptoms can worsen even while taking antibiotics, so do not wait for the next routine review when they are escalating.

Ask which test confirmed MRSA, whether the infection involves an implant or abscess, and what response will be monitored. Clarify the planned antibiotic route, medicine interactions, wound-care steps and activity limits. Ask what would lead to drainage, tissue removal or a change in treatment, and when the team will reassess the bone.